FDA Approves Sacituzumab Govitecan for First-Line Metastatic Triple-Negative Breast Cancer The U.S. Food and Drug Administration (FDA) has granted approval for sacituzumab govitecan (Trodelvy) as a first-line treatment for patients …
mammary gland
-
-
Addressing the Systemic Gender Gap in Healthcare Diagnostics and Investment The healthcare industry is shifting toward a life-course approach to women’s health, moving beyond reproductive care to address systemic diagnostic …
-
Scientists Identify Mechanism Behind Bird Flu Infections in Dairy Cattle Researchers have identified how the H5N1 avian influenza virus infects dairy cattle, according to a study published in *Nature* in …
-
Breastfeeding’s Lasting Impact: How Immune Cells Shape Maternal and Infant Health Breastfeeding is widely recognized for its benefits to both mother and child, but the intricate biological mechanisms driving these …
-
Breast Cancer Treatment Significantly Impacts Sexual Health, Study finds Table of Contents Breast Cancer Treatment Significantly Impacts Sexual Health, Study finds Prevalence of Sexual Health Concerns Limited Healthcare Support and …
-
Ritlecitinib: A New Dawn for Alopecia Areata Treatment? A wave of optimism is cresting in the alopecia areata (AA) community, thanks to groundbreaking results from the ALLEGRO-LT study. This long-term …
-
Should You Start Mammograms at 40? The Latest Guidelines Spark Debate The US Preventive Services Task Force (USPSTF) recently made headlines by recommending that average-risk women start mammograms at age …
-
Older Black Women Face Disparities in Breast Cancer Care A recent study published in *JAMA Network Open* has revealed concerning disparities in breast cancer care for older non-Hispanic Black women. …
-
Levongestrel IUD Linked to Increased Breast Cancer Risk: Danish Study A recent study conducted by Danish researchers suggests that the use of a levonorgestrel-releasing intrauterine system (LNG-IUS) may be associated …